Gambro Sale Of U.S. Dialysis Services Leaves $2 Bil. For Possible Acquisitions
This article was originally published in The Gray Sheet
Executive Summary
Gambro's plan to refocus on its core renal and blood bank product offerings by divesting its U.S. dialysis services business provides about $2 bil. for potential acquisitions in related fields